Inwentash buying at Avicanna (AVCN)

Inwentash buying at Avicanna (T:AVCN)

Sheldon Inwentash, a 10% Holder, acquired 25,800 Common Shares on a direct ownership basis at prices ranging from $1.480 to $1.500 between February 10th, and 16th, 2021. The insider also acquired 61,400 Common Shares on a control or direction basis for registered holder ThreeD Capital at prices ranging from $1.412 to $1.444 between February 11th and 16th, 2021. This represents a $126,341 investment into the company's shares and an account share holdings change of 3.9%.

Avicanna is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Avicanna Inc. is a Canada-based biopharmaceutical company. The Company is focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. In addition to its developing pharmaceutical pipeline, it has product lines, including Pura H&W and RHO Phyto. Pura H&W is a line of cannabidiol (CBD) consumer derma-cosmetic products. RHO Phyto is a line of medical cannabis products containing varying ratios of CBD and tetrahydrocannabinol (THC). The Company's subsidiary includes Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S.